Nanobots Therapeutics
PrivateLast Round
Seed
Dec 18, 2024
Est. Valuation
$7.81M
Total Funding Raised
$2.5M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Nanobots Therapeutics is a biotechnology company developing a nanorobot-based drug delivery platform, MotionTx, to deliver treatments directly to target tissues, with an initial focus on bladder cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanobots Therapeutics Comparables
Compare Nanobots Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoDrug Delivery GmbH | 81% | |
| Bionaut Labs | 77% | |
| Onselex Pharmaceuticals | 75% | |
Nanobots Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 18, 2024 | ||||
| Pre Seed | Sep 22, 2023 |
Key People
Founding team and executive leadership
Nanobots Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACCIÓ - Agency for Business Competitiveness | Pre Seed, Seed |
| Agencia Estatal de Investigación | Seed |
| Prous Institute for Biomedical Research | Pre Seed, Seed |
| BStartup Health | Seed, Pre Seed |
| Chasing Science | Pre Seed |
| BStartup Banco Sabadell | Pre Seed |
| Spanish Association Against Cancer | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 6, 12x the trailing average.
- Dec 18, 2024
$2M round from BStartup Health and others.
Nanobots Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nanobots Therapeutics's valuation, stock price, and market status.